Hillsdale Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,700	Closed	-$877K	–	638
2021 Q1	$877K	Hold	7,700	–	–	0.07%	266
2020 Q4	$1.07M	Sell	7,700 -3,500	-31%	-$485K	0.1%	206
2020 Q3	$921K	Buy	+11,200	New	+$921K	0.09%	195